Tuberculous orchiepididymitis after BCG therapy for bladder cancer.
Briceño-García
Eva M
EM
Radiology Service Department, Carlos Haya Hospital, Malaga, Spain. evambriceno@hotmail.com
Gómez-Pardal
Antonio
A
Alvarez-Bustos
Guillermo
G
Artero-Muñoz
Iván
I
Molinero
M Mar
MM
Seara-Valero
Raimundo
R
Moreno-Ramírez
Vanesa
V
D000283:Administration, Intravesical; D000368:Aged; D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D017577:Cutaneous Fistula / Q000000981:diagnostic imaging; D004822:Epididymis / Q000000981:diagnostic imaging; D004823:Epididymitis / Q000000981:diagnostic imaging / Q000382:microbiology*; D005402:Fistula / Q000000981:diagnostic imaging; D005832:Genital Diseases, Male / Q000000981:diagnostic imaging; D006801:Humans; D008297:Male; D009920:Orchitis / Q000000981:diagnostic imaging / Q000382:microbiology*; D014389:Tuberculosis, Male Genital / Q000000981:diagnostic imaging / Q000209:etiology*; D018615:Ultrasonography, Doppler, Color; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000601:surgery
D001500:BCG Vaccine